THE BRIDGE FROM GENOMICS TO NEW MEDICINES Trademark

Trademark Overview


On Wednesday, May 23, 2001, a trademark application was filed for THE BRIDGE FROM GENOMICS TO NEW MEDICINES with the United States Patent and Trademark Office. The USPTO has given the THE BRIDGE FROM GENOMICS TO NEW MEDICINES trademark a serial number of 78065179. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Sunday, March 7, 2010. This trademark is owned by Integrative Proteomics Inc.. The THE BRIDGE FROM GENOMICS TO NEW MEDICINES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Consultation, research and analysis for others in the fields of biotechnology, genomics, drug discovery and pharmaceuticals; scientific research; medical research; pharmaceutical research; research and development of new products for others

General Information


Serial Number78065179
Word MarkTHE BRIDGE FROM GENOMICS TO NEW MEDICINES
Filing DateWednesday, May 23, 2001
Status710 - CANCELLED - SECTION 8
Status DateSunday, March 7, 2010
Registration Number2744929
Registration DateTuesday, July 29, 2003
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 9, 2002

Trademark Statements


Goods and ServicesConsultation, research and analysis for others in the fields of biotechnology, genomics, drug discovery and pharmaceuticals; scientific research; medical research; pharmaceutical research; research and development of new products for others

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSunday, March 7, 2010
Primary Code042
First Use Anywhere DateWednesday, January 31, 2001
First Use In Commerce DateWednesday, January 31, 2001

Trademark Owner History


Party NameAFFINIUM PHARMACEUTICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTORONTO, ONTARIO M5J 1V6
CA

Party NameAFFINIUM PHARMACEUTICALS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressTORONTO, ONTARIO M5J 1V6
CA

Party NameIntegrative Proteomics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto, ONTARIO M5J 1V6
CA

Party NameIntegrative Proteomics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, ONTARIO M5J 1V6
CA

Trademark Events


Event DateEvent Description
Sunday, March 7, 2010CANCELLED SEC. 8 (6-YR)
Thursday, May 29, 2008CASE FILE IN TICRS
Tuesday, July 29, 2003REGISTERED-PRINCIPAL REGISTER
Saturday, May 17, 2003ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, April 24, 2003ASSIGNED TO EXAMINER
Wednesday, April 23, 2003STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 25, 2003USE AMENDMENT FILED
Tuesday, March 25, 2003TEAS STATEMENT OF USE RECEIVED
Tuesday, October 1, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 9, 2002PUBLISHED FOR OPPOSITION
Wednesday, June 19, 2002NOTICE OF PUBLICATION
Friday, March 8, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 24, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 14, 2001NON-FINAL ACTION MAILED
Friday, August 24, 2001ASSIGNED TO EXAMINER